FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130459043> ?p ?o ?g. }

• W2130459043 endingPage "608" @default.
• W2130459043 startingPage "601" @default.
• W2130459043 abstract "Between January 1991 and January 1993, 265 patients who fulfilled the CDC criteria of the working case definition of Chronic Fatigue Syndrome (CFS) have been observed at our Institution and submitted for clinical and laboratory evaluation. One hundred and sixty-three patients were females and 102 males, the median age was 35 years (range 4–55 years); all patients reported profound and prolonged fatigue, lasting for a median of 3 years (range 6 months–10 years), preceded or accompanied at appearance by fever in 185 cases, and neuropsychologic problems including inability to concentrate, difficulty in thinking, confusion, irritability, forgetfulness, and depression. The fatigue was so severe that it required 102 patients to stop their working activities for a period of time ranging from 3 months to 2 years (range 7 months). In 40 consecutive patients a comprehensive immunologic testing by single and two-colour flow cytometry was performed and results compared with a group of 35 healthy, age- and sex-matched controls. Whilst no significant differences were found in the absolute numbers of circulating total T cells (CD3+) and of total helper/inducer (CD4+) or suppressor/cytotoxic (CDS+) T cells, an evident reduction in CD3−/CD16+ and CD57+/CD56+ NK lymphocytes along with an expansion of the CD8+/CD56+ and CD16−/CD56+ NK subsets, were found in the CFS group. In addition, CD56+ NK cells from CFS subjects were found to express an increased amount of cell adhesion molecules (CD11b. CD1 1c, CD54) and activation antigens (CD38). Both the percentage and absolute numbers of CD4+ T cells bearing the CD45RA antigen appeared significantly reduced in CFS patients, and CD4+ T lymphocytes from CFS subjects displayed an increased expression of the intercellular adhesion molecule-1 (ICAM− 1/CD54). Finally, the total numbers of circulating (CD19+) B lymphocytes, were significantly higher in CFS cases than in controls, and in 11 out of 30 CFS patients the increase in circulating B cells was sustained by the expansion of the CD5+/CD19+ subset of B lymphocytes. We conclude that CFS is a syndrome not previously described in Italy, with already known clinical characteristics and appears to be associated with several immunologic abnormalities, including those reported previously in cohort of patients from different countries. We also show for the first time that CD56+ NK cell subsets from CFS patients display an abnormally increased expression of cell adhesion molecules and activation markers." @default.
• W2130459043 created "2016-06-24" @default.
• W2130459043 creator A5019598602 @default.
• W2130459043 creator A5033029228 @default.
• W2130459043 creator A5038699632 @default.
• W2130459043 creator A5041556876 @default.
• W2130459043 date "1994-12-01" @default.
• W2130459043 modified "2023-09-25" @default.
• W2130459043 title "Immunological Abnormalities in Patients with Chronic Fatigue Syndrome" @default.
• W2130459043 cites W114039586 @default.
• W2130459043 cites W1504038693 @default.
• W2130459043 cites W1542501019 @default.
• W2130459043 cites W1568059997 @default.
• W2130459043 cites W1858496028 @default.
• W2130459043 cites W187255673 @default.
• W2130459043 cites W1916663363 @default.
• W2130459043 cites W1934388450 @default.
• W2130459043 cites W1963829537 @default.
• W2130459043 cites W1964527338 @default.
• W2130459043 cites W1969465160 @default.
• W2130459043 cites W1987200092 @default.
• W2130459043 cites W1989937696 @default.
• W2130459043 cites W1990961599 @default.
• W2130459043 cites W1992707199 @default.
• W2130459043 cites W1993492728 @default.
• W2130459043 cites W1998891861 @default.
• W2130459043 cites W2003967896 @default.
• W2130459043 cites W2009075951 @default.
• W2130459043 cites W2012204136 @default.
• W2130459043 cites W2020273287 @default.
• W2130459043 cites W2032679326 @default.
• W2130459043 cites W2060599764 @default.
• W2130459043 cites W2064021071 @default.
• W2130459043 cites W2068835017 @default.
• W2130459043 cites W2073673318 @default.
• W2130459043 cites W2085022819 @default.
• W2130459043 cites W2087384036 @default.
• W2130459043 cites W2138995305 @default.
• W2130459043 cites W2146451383 @default.
• W2130459043 cites W2149522551 @default.
• W2130459043 cites W2158605298 @default.
• W2130459043 cites W2314331148 @default.
• W2130459043 cites W2330717438 @default.
• W2130459043 cites W2338035413 @default.
• W2130459043 cites W4247313162 @default.
• W2130459043 doi "https://doi.org/10.1111/j.1365-3083.1994.tb03511.x" @default.
• W2130459043 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7997849" @default.
• W2130459043 hasPublicationYear "1994" @default.
• W2130459043 type Work @default.
• W2130459043 sameAs 2130459043 @default.
• W2130459043 citedByCount "106" @default.
• W2130459043 countsByYear W21304590432012 @default.
• W2130459043 countsByYear W21304590432013 @default.
• W2130459043 countsByYear W21304590432014 @default.
• W2130459043 countsByYear W21304590432015 @default.
• W2130459043 countsByYear W21304590432016 @default.
• W2130459043 countsByYear W21304590432017 @default.
• W2130459043 countsByYear W21304590432018 @default.
• W2130459043 countsByYear W21304590432019 @default.
• W2130459043 countsByYear W21304590432021 @default.
• W2130459043 countsByYear W21304590432022 @default.
• W2130459043 countsByYear W21304590432023 @default.
• W2130459043 crossrefType "journal-article" @default.
• W2130459043 hasAuthorship W2130459043A5019598602 @default.
• W2130459043 hasAuthorship W2130459043A5033029228 @default.
• W2130459043 hasAuthorship W2130459043A5038699632 @default.
• W2130459043 hasAuthorship W2130459043A5041556876 @default.
• W2130459043 hasConcept C114684123 @default.
• W2130459043 hasConcept C126322002 @default.
• W2130459043 hasConcept C139719470 @default.
• W2130459043 hasConcept C147483822 @default.
• W2130459043 hasConcept C162324750 @default.
• W2130459043 hasConcept C167672396 @default.
• W2130459043 hasConcept C203014093 @default.
• W2130459043 hasConcept C2776867660 @default.
• W2130459043 hasConcept C2778562196 @default.
• W2130459043 hasConcept C2779566273 @default.
• W2130459043 hasConcept C2780820931 @default.
• W2130459043 hasConcept C2781462264 @default.
• W2130459043 hasConcept C71924100 @default.
• W2130459043 hasConcept C90924648 @default.
• W2130459043 hasConceptScore W2130459043C114684123 @default.
• W2130459043 hasConceptScore W2130459043C126322002 @default.
• W2130459043 hasConceptScore W2130459043C139719470 @default.
• W2130459043 hasConceptScore W2130459043C147483822 @default.
• W2130459043 hasConceptScore W2130459043C162324750 @default.
• W2130459043 hasConceptScore W2130459043C167672396 @default.
• W2130459043 hasConceptScore W2130459043C203014093 @default.
• W2130459043 hasConceptScore W2130459043C2776867660 @default.
• W2130459043 hasConceptScore W2130459043C2778562196 @default.
• W2130459043 hasConceptScore W2130459043C2779566273 @default.
• W2130459043 hasConceptScore W2130459043C2780820931 @default.
• W2130459043 hasConceptScore W2130459043C2781462264 @default.
• W2130459043 hasConceptScore W2130459043C71924100 @default.
• W2130459043 hasConceptScore W2130459043C90924648 @default.
• W2130459043 hasIssue "6" @default.
• W2130459043 hasLocation W21304590431 @default.
• W2130459043 hasLocation W21304590432 @default.

• next